Our Vision:

2024 has been a transformative year for myeloma care, marked by groundbreaking advancements and hope for patients worldwide. In this week’s blog, IMF Chief Medical Officer Dr. Joseph Mikhael highlights pivotal milestones, including FDA approval of innovative 4-drug therapies, promising trends in CAR T-cell treatments and immunotherapy, and international collaborations addressing health equity.  READ THE BLOG.

In case you missed it, IMF Chief Medical Officer Dr. Joseph Mikhael and our support group leaders went live on Facebook on the evening of Monday, December 9, to discuss the key myeloma research takeaways from the 2024 American Society of Hematology Meeting. You don't have to be a member of Facebook to watch the replay. Click the link to watch this lively discussion: LEARN MORE.

At the upcoming International Myeloma Working Group (IMWG) Conference Series: “Making Sense of Treatment,” leading experts will discuss key advances in multiple myeloma research from the 2024 American Society of Hematology (ASH) Conference. Moderated by IMF Chief Medical Officer Joseph Mikhael, MD, MEd, FRCPC, FACPP (TGen at the City of Hope – Phoenix), the panel includes IMF Nurse Leadership Board Member Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (Cleveland Clinic, Taussig Cancer Center – Cleveland); Nikhil Munshi, MD (Dana-Farber Cancer Institute – Boston); and IMF Chairperson of the Board S. Vincent Rajkumar, MD (Mayo Clinic – Rochester, MN). Topics will cover monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), current challenges, frontline therapies, immune therapies such as CAR T-cell and bispecific antibodies, and novel drugs. Dr. Mikhael will share highlights from the ASH abstracts and the IMF IMWG Breakfast. Don’t miss this live event on December 18, 2024! SAVE MY SEAT. 

Tune in as the IMF brings myeloma support group leaders and patients to the hybrid 66th annual meeting of the American Society of Hematology (ASH), an exciting convergence of 10,000 health care professionals from around the world. Start following the IMF ASH team members now on social media as they ramp up to share the latest clinical updates in myeloma research, therapies, and practice strategies via Twitter (#ASH24 and #IMFASH24), Facebook, blogs, and videos. VISIT THE WEBSITE NOW.

Join IMF Chief Medical Officer Dr. Joseph Mikhael and an expert panel for an exclusive webinar highlighting key takeaways from the 2024 ASH Conference, where over 1,000 myeloma-focused abstracts were presented. This webinar will take place on Wednesday, January 8, 2025  at 3:00 PM PST | 4:00 PM MDT | 5:00 PM CT | 6:00 PM ET. Discover the latest in CAR T-cell therapy, bispecific antibodies, and MRD testing, along with insights into quality of life, real-world data, and health disparities. Hear from patient advocates and support group leaders as they share the patient perspective. Register today to secure your spot for this discussion. SAVE MY SEAT.

The IMF’s Miracles for Myeloma Virtual/In-Person 5K Run/Walk will take place on Saturday, March 15, 2025, at 7:00 a.m. EST in Boca Raton, Florida. The race starts and finishes at the Boca Raton Marriott at Boca Center (5150 Town Center Circle). All proceeds from this event will fund the IMF’s life-saving research and work to find a cure. Register to run in person, or from any location in the world. You may also choose to honor a loved one along the Remembrance Path. LEARN MORE.